Artiva Biotherapeutics (ARTV) Stock Insights

ARTV price $4.30 +0.03 +0.70%

Ticker
ARTV
Price
$4.30
Change
+0.03 +0.70%
Market cap ?
$210.23M
P/E ?
-1.86
Dividend yield ?
0.00%
Beta ?
2.41
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
70
Value
57
Quality
52
Growth
100

Stocklytics score rationale: value 57, quality 52, growth 100.

Financials

202020212022202320242025
020020004931000334920002510000

Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology firm specializing in the development of natural killer (NK) cell-based treatments for individuals afflicted with autoimmune disorders and various forms of cancer. Its flagship therapeutic candidate, AB-101, is an innovative, ready-to-use (off-the-shelf) NK cell therapy. This treatment is being developed for a broad spectrum of conditions, including…

Fair value

ARTV fair value Not meaningful. Price $4.30.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare ARTV

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.54——
2026-08-06-0.63-0.63——
2026-05-08-0.95-0.88——
2026-03-10-0.84-0.87——
2025-11-12-0.88-0.92——
2025-08-06-0.87-0.84——
2025-05-08-0.83-0.68——
2025-03-25-0.66-0.71——
2024-11-12-0.92-0.68——
2024-08-29-22.00-4.40—100.00K
2024-06-28-0.79-1.38251.00K100.00K
2023-12-31-0.30—33.49M—
2023-09-301.20—26.66M—
2023-06-30-0.90———
2023-03-31-0.95—989.00K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-06Aslan FredSell23.46K$7.20168.88K
2026-10-05Horan ChristopherSell10.34K$6.8470.70K
2026-10-05Bush JenniferSell8.37K$6.8457.23K
2026-10-05Banerjee SubhashisSell1.10K$6.847.51K
2026-10-05Aslan FredSell61.70K$6.84421.83K
2026-09-15Aslan FredBuy110.00K——
2026-09-15Aslan FredBuy315.00K$8.912.81M
2026-09-10Aslan FredBuy45.00K——
2026-09-10Aslan FredBuy155.00K$10.421.62M
2026-09-10RA CAPITAL MANAGEMENT, L.P.Buy16.25K$10.42169.32K
2026-09-10Stoppel LauraBuy16.25K$10.42169.32K
2026-09-10Sorg Elaine K.Buy16.25K$10.42169.32K
2026-09-10HOUGEN ELIZABETH LBuy16.25K$10.42169.32K
2026-09-10DANIELS BRIANBuy16.25K$10.42169.32K
2026-09-10Baker Daniel G.Buy16.25K$10.42169.32K
2026-09-10MOORE ALISONBuy16.25K$10.42169.32K
2026-09-09Miralles Gines DiegoBuy135.00K$10.791.46M
2026-09-09Miralles Gines DiegoBuy45.00K——
2026-09-09Horan ChristopherBuy40.00K——
2026-09-09Horan ChristopherBuy120.00K$10.791.29M
2026-09-09Bush JenniferBuy45.00K——
2026-09-09Bush JenniferBuy135.00K$10.791.46M
2026-09-09Banerjee SubhashisBuy30.00K——
2026-09-09Banerjee SubhashisBuy85.00K$10.79917.15K
2026-09-08Aslan FredSell23.43K$10.92255.75K
2026-09-08RA CAPITAL MANAGEMENT, L.P.Buy13.75K$10.88149.60K
2026-09-08Stoppel LauraBuy13.75K$10.88149.60K
2026-09-08Sorg Elaine K.Buy13.75K$10.88149.60K
2026-09-08HOUGEN ELIZABETH LBuy13.75K$10.88149.60K
2026-09-08DANIELS BRIANBuy13.75K$10.88149.60K
2026-09-08Baker Daniel G.Buy13.75K$10.88149.60K
2026-09-08MOORE ALISONBuy13.75K$10.88149.60K
2026-09-03Horan ChristopherSell10.37K$11.16115.64K
2026-09-03Bush JenniferSell8.39K$11.1693.61K
2026-09-03Banerjee SubhashisSell1.10K$11.1612.27K
2026-09-03Aslan FredSell61.89K$11.16690.39K
2026-08-27Banerjee SubhashisBuy5.31K$1.9210.19K
2026-08-27Banerjee SubhashisSell8.22K$12.0198.74K
2026-08-27Banerjee SubhashisSell5.31K$1.9210.19K
2026-08-18Banerjee SubhashisBuy429$1.92824
2026-08-18Banerjee SubhashisSell429$12.005.15K
2026-08-18Banerjee SubhashisSell429$1.92824
2026-07-31RA CAPITAL MANAGEMENT, L.P.Buy24.94K$9.93247.69K
2026-07-29RA CAPITAL MANAGEMENT, L.P.Buy20.82K$9.99208.03K
2026-07-24RA CAPITAL MANAGEMENT, L.P.Buy41.32K$9.99412.78K
2026-07-23RA CAPITAL MANAGEMENT, L.P.Buy59.88K$9.96596.40K
2026-07-22RA CAPITAL MANAGEMENT, L.P.Buy84.12K$9.93835.35K
2026-07-21RA CAPITAL MANAGEMENT, L.P.Buy120.58K$9.551.15M
2026-07-17RA CAPITAL MANAGEMENT, L.P.Buy7.88K$8.9570.54K
2026-07-16RA CAPITAL MANAGEMENT, L.P.Buy152.47K$8.931.36M
2026-07-13RA CAPITAL MANAGEMENT, L.P.Buy6.52K$8.9458.31K
2026-07-13RA CAPITAL MANAGEMENT, L.P.Buy6.55K$8.9458.57K
2026-07-10RA CAPITAL MANAGEMENT, L.P.Buy15.10K$8.97135.46K
2026-06-26RA CAPITAL MANAGEMENT, L.P.Buy1.88K$8.9816.85K
2026-06-25RA CAPITAL MANAGEMENT, L.P.Buy31.00K$8.88275.28K
2026-06-16RA CAPITAL MANAGEMENT, L.P.Buy124.89K$8.891.11M
2026-06-15RA CAPITAL MANAGEMENT, L.P.Buy15.41K$8.99138.57K
2026-06-12RA CAPITAL MANAGEMENT, L.P.Buy391.02K$8.573.35M
2026-06-11RA CAPITAL MANAGEMENT, L.P.Buy548.58K$7.914.34M
2026-06-10RA CAPITAL MANAGEMENT, L.P.Buy103$7.00721
2026-06-09RA CAPITAL MANAGEMENT, L.P.Buy479.04K$6.913.31M
2026-05-19Raymon HeatherSell3.10K$9.0127.88K
2026-05-19Horan ChristopherSell7.00K$9.0163.07K
2026-05-19Bush JenniferSell8.79K$9.0179.18K
2026-05-19Banerjee SubhashisSell7.04K$9.0163.39K
2026-05-19Aslan FredSell27.12K$9.01244.25K
2026-05-18Miralles Gines DiegoBuy232.50K$9.222.14M
2026-05-18Miralles Gines DiegoBuy77.50K——
2026-05-11GC Corp.Buy1.09M$11.5212.50M
2026-05-11GC Corp.Buy347.22K$11.524.00M
2026-05-11RA CAPITAL MANAGEMENT, L.P.Buy6.51M$11.5275.00M
2026-05-11RA CAPITAL MANAGEMENT, L.P.Buy2.17M$0.00217
2026-03-10Huston Thad AllenBuy220.00K——
2026-02-18Huston Thad AllenOther0——
2026-02-18Sorg Elaine K.Buy27.50K$4.15114.13K
2026-02-18Sorg Elaine K.Other0——
2026-02-15Raymon HeatherBuy46.00K——
2026-02-15Raymon HeatherSell1.52K$4.006.08K
2026-02-15Horan ChristopherBuy117.30K——
2026-02-15Horan ChristopherSell2.19K$4.008.75K
2026-02-15Bush JenniferBuy117.30K——
2026-02-15Bush JenniferSell3.52K$4.0014.06K
2026-02-15Banerjee SubhashisBuy102.00K——
2026-02-15Aslan FredBuy366.85K——
2026-02-15Aslan FredSell14.60K$4.0058.40K
2025-12-15Aslan FredSell3.19K$6.0019.12K
2025-12-12Raymon HeatherBuy67.25K——
2025-12-12Raymon HeatherSell14.82K$5.0174.24K
2025-12-12Raymon HeatherSell18.24K$5.1493.75K
2025-12-12Raymon HeatherSell11.40K$5.1859.05K
2025-12-12Raymon HeatherSell10.26K$13.47138.19K
2025-12-12Horan ChristopherBuy107.16K——
2025-12-12Horan ChristopherSell9.12K$5.0145.69K
2025-12-12Horan ChristopherSell20.52K$13.47276.39K
2025-12-12Bush JenniferBuy84.88K——
2025-12-12Bush JenniferSell9.12K$5.0145.69K
2025-12-12Bush JenniferSell20.52K$13.47276.39K
2025-12-12Bush JenniferSell14.20K$5.1873.57K
2025-12-12Aslan FredBuy869.14K——
2025-12-12Aslan FredSell26.45K$5.18137.01K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 74, holders +34 vs prior quarter. Ownership 102.47%.

HolderSharesChangeChange %Value
RA CAPITAL MANAGEMENT, L.P.17.96M8.10M+82.23%174.17M
VIKING GLOBAL INVESTORS LP2.60M2.60MNew25.26M
BLACKSTONE INC.2.40M2.40MNew23.31M
5AM VENTURE MANAGEMENT, LLC2.35M00.00%22.83M
VENROCK ADVISER, LLC2.04M434.03K+26.97%19.82M
FRANKLIN TEMPLETON INC2.00M1.48M+283.84%19.37M
CALIGAN PARTNERS LP1.74M1.74MNew16.84M
VANGUARD CAPITAL MANAGEMENT LLC981.82K774.13K+372.74%9.52M
SAMSARA BIOCAPITAL, LLC954.86K954.86KNew9.26M
BLUE OWL CAPITAL HOLDINGS LP874.54K874.54KNew8.48M
PROPEL BIO MANAGEMENT, LLC696.44K550.07K+375.81%6.76M
BLACKROCK, INC.694.73K481.34K+225.57%6.74M
CITADEL ADVISORS LLC609.38K593.51K+3739.80%5.91M
SILVERARC CAPITAL MANAGEMENT, LLC525.00K525.00KNew5.09M
GEODE CAPITAL MANAGEMENT, LLC353.85K252.15K+247.95%3.43M
BOOTHBAY FUND MANAGEMENT, LLC314.38K314.38KNew3.05M
NANTAHALA CAPITAL MANAGEMENT, LLC300.00K300.00KNew2.91M
REVELATION CAPITAL MANAGEMENT, LLC299.31K00.00%2.90M
ALYESKA INVESTMENT GROUP, L.P.273.62K173.62K+173.62%2.65M
ACUTA CAPITAL PARTNERS, LLC260.42K260.42KNew2.53M
KVP CAPITAL ADVISORS, LP200.00K200.00KNew1.94M
WELLINGTON MANAGEMENT GROUP LLP194.11K00.00%1.88M
UBS GROUP AG184.02K182.49K+11951.08%1.78M
SEVEN GRAND MANAGERS, LLC175.00K175.00KNew1.70M
STATE STREET CORP165.76K129.94K+362.72%1.61M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Artiva Biotherapeutics (ARTV) Stock Insights

ARTV$4.30+0.03 +0.70%

$210.23M

Market Cap

-1.86

P/E

—

Forward P/E

70

Score

Price History